Progestogen therapy and prevention of functional ovarian cysts during pituitary desensitisation with GnRH agonists

K Aston, Kayleigh Aston, Ian Arthur, I Arthur, G M Masson, J M Jenkins
British journal of obstetrics and gynaecology · 1995 · vol. 102(10) , pp. 835–837 · doi:10.1111/j.1471-0528.1995.tb10853.x · PMID:7547744 · W2076534796
RCT OA: closed CC0 ⤵ 1 in-corpus citation
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This study investigated whether progestogen therapy effectively prevents functional ovarian cyst development in women undergoing pituitary desensitization with GnRH agonists.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

MeSH descriptors

Antineoplastic Agents, Hormonal Buserelin Ovarian Cysts Progestins Administration, Intranasal Adult Antineoplastic Agents, Hormonal Buserelin Double-Blind Method Female Follicular Phase Follicular Phase Humans Ovarian Cysts Pituitary Gland Pituitary Gland Progestins Prospective Studies

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Cited by (1)

References (6)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:58:49.153990+00:00
unpaywall
last seen: 2026-11-05T06:08:55.941966+00:00
License: CC0 · commercial use OK